Hui Tian
- Cancer Research top 10%
- Oncology top 10%
- Peptidase Inhibition and Analysis 6
- Cancer-related Molecular Pathways 5
-
- RNA modifications and cancer 9
- PI3K/AKT/mTOR signaling in cancer 6
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 12
-
- Radiomics and Machine Learning in Medical Imaging 6
-
- Microtubule and mitosis dynamics 4
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hui Tian
85 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 193
- Oncology 331
- Molecular Biology 626
- Pulmonary and Respiratory Medicine 149
- Pathology and Forensic Medicine 80
Countries citing papers authored by Hui Tian
This map shows the geographic impact of Hui Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Tian more than expected).
Fields of papers citing papers by Hui Tian
This network shows the impact of papers produced by Hui Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Tian. The network helps show where Hui Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2021 | 20 | |
| 13 | 2016 | 24 | |
| 14 | Effect of meteorological conditions on occurrence of Hand-Foot-Mouth disease and the application of prediction model | 2013 | 1 |
| 15 | 2013 | 25 | |
| 16 | 2013 | 15 | |
| 17 | Analysis of enterovirus-carrying situation in healthy children in Zanhuang county of Shijiazhuang. | 2012 | 1 |
| 18 | 2011 | 48 | |
| 19 | Age Structure and Growth Characteristic of Garra orientalis from the Nujiang River | 2010 | 0 |
| 20 | 2006 | 29 |
About Hui Tian
Hui Tian is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, having authored 97 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (12 papers), RNA modifications and cancer (9 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Peptidase Inhibition and Analysis (6 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Cancer-related Molecular Pathways (5 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Cancer Research (193 citations), Oncology (331 citations) and Molecular Biology (626 citations). Hui Tian has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Timothy J. Jorgensen, Shuhai Li, Weiming Yue, Yixi Bao, Zijing Liu, Lin Li, Youwei Pu, Wenjun Li, Cun Gao and Lei Qi. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.